Pharmacyclics Reports Recent Developments and Financial Results for Fiscal Third Quarter 2011
by on Thursday, May 5th, 2011 | No Comments
… initiated a broad Phase II clinical development program in chronic lymphocytic leukemia, mantle cell lymphoma and diffuse large B-cell lymphoma. This program was designed to enable Phase III decisions …
Read the original here: Pharmacyclics Reports Recent Developments and Financial Results for Fiscal Third Quarter 2011